Overcoming Preexisting Humoral Immunity to AAV Using Capsid DecoysFederico Mingozzi, Katherine A. High, Xavier M. Anguela et al.|Science Translational Medicine|2013Cited by 346
Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cellsAshley T. Martino, Roland W. Herzog, Etiena Basner‐Tschakarjan et al.|Blood|2013Cited by 160
Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal modelsYafeng Song, Hansell H. Stedman, Leon Morales et al.|Nature Medicine|2019Cited by 94
Modulation of CD8+ T cell responses to AAV vectors with IgG-derived MHC class II epitopesDaniel J. Hui, Federico Mingozzi, Etiena Basner‐Tschakarjan et al.|Molecular Therapy|2013Cited by 45
Amelioration of Neurosensory Structure and Function in Animal and Cellular Models of a Congenital BlindnessJi Yun Song, Jean Bennett, Jennifer Pham et al.|Molecular Therapy|2018Cited by 27